Victor M. Cnossen
YOU?
Author Swipe
View article: Development of an intranasal, universal influenza vaccine in an EU-funded public-private partnership: the FLUniversal consortium
Development of an intranasal, universal influenza vaccine in an EU-funded public-private partnership: the FLUniversal consortium Open
Influenza is a significant global health problem, causing disease and hospitalisations in elderly individuals and infants. While updated vaccines are available every year, their effectiveness is moderate at best. FLUniversal is a European …
View article: Regulatory workshop on standardisation of clinical procedures, endpoints and data robustness of human challenge studies – A stakeholder meeting report
Regulatory workshop on standardisation of clinical procedures, endpoints and data robustness of human challenge studies – A stakeholder meeting report Open
Inno4Vac, a public-private partnership funded by the IMI2/EU/EFPIA Joint Undertaking (IMI2 JU), brings together academic institutions, SMEs, and pharmaceutical companies to accelerate and de-risk vaccine development. The project has made s…
View article: From setbacks to success: lessons from the journey of RSV vaccine development
From setbacks to success: lessons from the journey of RSV vaccine development Open
Respiratory syncytial virus (RSV) causes high worldwide infant mortality, as well as a high disease burden in the elderly. Efforts in vaccine development over the past 60 years have recently delivered three approved vaccines and two monocl…